• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载氟比洛芬纳米球:用热分析法分析基质结构

Flurbiprofen-loaded nanospheres: analysis of the matrix structure by thermal methods.

作者信息

Gamisans F, Lacoulonche F, Chauvet A, Espina M, García M L, Egea M A

机构信息

Physicochemical Unit, Department of Pharmacy, Faculty of Pharmacy, Avda Juan XXIII s/n, 08028, Barcelona, Spain.

出版信息

Int J Pharm. 1999 Mar 1;179(1):37-48. doi: 10.1016/s0378-5173(98)00381-0.

DOI:10.1016/s0378-5173(98)00381-0
PMID:10053200
Abstract

We report the preparation and evaluation of flurbiprofen loaded-poly-epsilon-caprolactone nanospheres obtained by solvent displacement method. Characterization by thermal methods, infrared spectroscopy and X-ray diffraction analysis can reveal the dispersion state of the drug inside the nanospheres. Such information predicts the stability of the particles and the drug release behaviour. The study has indicated the presence of a molecular dispersed system. In addition, construction of a phase diagram has allowed us to determine the drug/polymer ratios at which flurbiprofen has the highest entrapment efficiency.

摘要

我们报告了通过溶剂置换法制备的载有氟比洛芬的聚ε-己内酯纳米球及其评估。通过热方法、红外光谱和X射线衍射分析进行表征,可以揭示药物在纳米球内的分散状态。此类信息可预测颗粒的稳定性和药物释放行为。该研究表明存在分子分散体系。此外,相图的构建使我们能够确定氟比洛芬具有最高包封率时的药物/聚合物比例。

相似文献

1
Flurbiprofen-loaded nanospheres: analysis of the matrix structure by thermal methods.载氟比洛芬纳米球:用热分析法分析基质结构
Int J Pharm. 1999 Mar 1;179(1):37-48. doi: 10.1016/s0378-5173(98)00381-0.
2
PLGA nanospheres for the ocular delivery of flurbiprofen: drug release and interactions.用于氟比洛芬眼部给药的聚乳酸-羟基乙酸共聚物纳米球:药物释放与相互作用
J Pharm Sci. 2008 Dec;97(12):5306-17. doi: 10.1002/jps.21383.
3
Cyclophosphamide-loaded nanospheres: analysis of the matrix structure by thermal and spectroscopic methods.
J Microencapsul. 2002 May-Jun;19(3):305-10. doi: 10.1080/02652040110081352.
4
Design and evaluation of temperature-responsive chitosan/hydroxypropyl cellulose blend nanospheres for sustainable flurbiprofen release.设计和评价温度响应性壳聚糖/羟丙基纤维素共混纳米球用于可持续释放氟比洛芬。
Int J Biol Macromol. 2020 Sep 15;159:751-762. doi: 10.1016/j.ijbiomac.2020.05.071. Epub 2020 May 13.
5
Formulation and evaluation of flurbiprofen-loaded genipin cross-linked gelatin microspheres for intra-articular delivery.载氟比洛芬的京尼平交联明胶微球的制备及评价用于关节内给药。
J Drug Target. 2013 Feb;21(2):200-10. doi: 10.3109/1061186X.2012.745549. Epub 2012 Dec 19.
6
Lappaconitine-loaded microspheres for parenteral sustained release: effects of formulation variables and in vitro characterization.用于肠胃外缓释的高乌甲素微球:制剂变量的影响及体外特性研究
Pharmazie. 2011 Sep;66(9):654-61.
7
Intra-articular delivery of genipin cross-linked chitosan microspheres of flurbiprofen: preparation, characterization, in vitro and in vivo studies.关节内注射金合欢素交联壳聚糖氟比洛芬微球的制备、表征、体外及体内研究。
Eur J Pharm Biopharm. 2012 Aug;81(3):563-72. doi: 10.1016/j.ejpb.2012.04.018. Epub 2012 May 14.
8
Flurbiprofen-loaded niosomes-in-gel system improves the ocular bioavailability of flurbiprofen in the aqueous humor.载有氟比洛芬的囊泡凝胶系统提高了氟比洛芬在房水中的眼内生物利用度。
Drug Dev Ind Pharm. 2017 Jun;43(6):902-910. doi: 10.1080/03639045.2016.1272120. Epub 2017 Jan 31.
9
Encapsulation and characterization of controlled release flurbiprofen loaded microspheres using beeswax as an encapsulating agent.采用蜂蜡作为包封剂的载氟比洛芬控释微球的包封与特性研究。
J Mater Sci Mater Med. 2010 May;21(5):1621-30. doi: 10.1007/s10856-010-4034-4. Epub 2010 Mar 10.
10
Preparation and characterization of flurbiprofen-loaded poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microspheres.载氟比洛芬聚(3-羟基丁酸酯-co-3-羟基戊酸酯)微球的制备与表征
J Microencapsul. 2008 May;25(3):170-8. doi: 10.1080/02652040701814140.

引用本文的文献

1
Preparation, Characterization, Antioxidant Activities, and Determination of Anti-Alzheimer Effects of PLGA-Based DDSs Containing Ferulic Acid.含阿魏酸的聚乳酸-羟基乙酸共聚物基药物递送系统的制备、表征、抗氧化活性及抗阿尔茨海默病作用的测定
ACS Omega. 2024 Feb 29;9(10):11321-11338. doi: 10.1021/acsomega.3c07289. eCollection 2024 Mar 12.
2
Recent Advances in the Design of Topical Ophthalmic Delivery Systems in the Treatment of Ocular Surface Inflammation and Their Biopharmaceutical Evaluation.用于治疗眼表炎症的局部眼用给药系统的设计进展及其生物药剂学评价
Pharmaceutics. 2020 Jun 19;12(6):570. doi: 10.3390/pharmaceutics12060570.
3
Clarithromycin-Loaded Poly (Lactic--glycolic Acid) (PLGA) Nanoparticles for Oral Administration: Effect of Polymer Molecular Weight and Surface Modification with Chitosan on Formulation, Nanoparticle Characterization and Antibacterial Effects.
口服克拉霉素负载聚(乳酸-乙醇酸)(PLGA)纳米粒:聚合物分子量及壳聚糖表面修饰对制剂、纳米粒表征和抗菌效果的影响
Polymers (Basel). 2019 Oct 9;11(10):1632. doi: 10.3390/polym11101632.
4
Boosting Drug Discovery for Parkinson's: Enhancement of the Delivery of a Monoamine Oxidase-B Inhibitor by Brain-Targeted PEGylated Polycaprolactone-Based Nanoparticles.助力帕金森病药物研发:脑靶向聚乙二醇化聚己内酯纳米颗粒增强单胺氧化酶B抑制剂的递送
Pharmaceutics. 2019 Jul 12;11(7):331. doi: 10.3390/pharmaceutics11070331.
5
Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.载盐酸美金刚 PLGA-PEG 纳米粒用于治疗阿尔茨海默病:体外与体内特性研究。
J Nanobiotechnology. 2018 Mar 27;16(1):32. doi: 10.1186/s12951-018-0356-z.
6
Encapsulation of (Piperaceae) nonpolar extract in poly(methyl methacrylate) by miniemulsion and evaluation of increase in the effectiveness of antileukemic activity in K562 cells.通过细乳液法将胡椒科非极性提取物包封于聚甲基丙烯酸甲酯中,并评估其对K562细胞抗白血病活性有效性的增强作用。
Int J Nanomedicine. 2017 Nov 21;12:8363-8373. doi: 10.2147/IJN.S134756. eCollection 2017.
7
Nanoparticles Based on Chitosan as Carriers for the Combined Herbicides Imazapic and Imazapyr.基于壳聚糖的纳米颗粒作为除草剂甲氧咪草烟和咪唑乙烟酸组合的载体
Sci Rep. 2016 Jan 27;6:19768. doi: 10.1038/srep19768.
8
Poly(lactide-co-glycolide) nanocapsules containing benzocaine: influence of the composition of the oily nucleus on physico-chemical properties and anesthetic activity.载苯佐卡因聚乳酸-聚乙醇酸纳米囊:油核组成对理化性质和麻醉活性的影响。
Pharm Res. 2011 Aug;28(8):1984-94. doi: 10.1007/s11095-011-0425-6. Epub 2011 Apr 7.